Abstract

The symptoms of rheumatoid arthritis (RA) are based on the many processes; chronic inflammation, overgrowth of synovial cells, bone and joint destruction and fibrosis. To clarify the mechanism of outgrowth of synovial cells, we carried out immunoscreening using anti-rheumatoid synovial cell antibody, and cloned 'Synoviolin'. Synoviolin, a mammalian homolog of Hrd1p/Der3p, is endoplasmic reticulum (ER)-resident E3 ubiquitin ligases with a RING motif, and is involved in ER-associated degradation (ERAD). Synoviolin is highly expressed in synoviocytes of patients with RA. Overexpression of synoviolin in transgenic mice leads to advanced arthropathy caused by reduced apoptosis of synoviocytes. We postulate that the hyperactivation of the ERAD pathway by overexpression of synoviolin results in prevention of ER-stress-induced apoptosis leading to synovial hyperplasia. Indeed, synoviolin+/- knockout mice showed resistance to the development of collagen-induced arthritis owing to enhanced apoptosis of synovial cells. In addition, Synoviolin ubiquitinates and sequesters the tumor suppressor p53 in the cytoplasm, thereby negatively regulating its biological functions in transcription, cell-cycle regulation and apoptosis by targeting it for proteasomal degradation. Therefore Synoviolin regulates, not only apoptosis in response to ER stress, but also a p53-dependent apoptotic pathway. These studies indicate that Synoviolin is one of the causative factors of arthropathy. Further analysis using gene targeting approaches showed that in addition to its role in RA, Synoviolin is essential for embryogenesis. Synoviolin deficient (syno-/-) mice exhibited severe anemia caused by enhancement of apoptosis in fetal liver, and the results suggested that the liver is sensitive organ for Synoviolin. Thus, this study aimed to explore the involvement of the Synoviolin in fibrosis process of RA using mice model of liver fibrosis. In CCl4-induced hepatic injury model, syno+/- mice are resistant to onset of liver fibrosis. The number of activated HSCs was decreased in syno+/- mice, and some of these cells showed apoptosis. Furthermore, collagen expression in HSCs was upregulated by synoviolin overexpression, while synoviolin knockdown led to reduced collagen expression. Moreover, in syno-/- MEFs, the amounts of intracellular and secreted mature collagen were significantly decreased, and procollagen was abnormally accumulated in the endoplasmic reticulum. In conclusion, Synoviolin is involved in not only overgrowth process of synovial cells but also fibrosis process.

Highlights

  • Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations in a number of demyelinating disorders including multiple sclerosis (MS) and collagen diseases

  • tumor necrosis factor (TNF) therapy and demyelinating event: A report indicates that adverse events such as the demyelinating lesion in the brain, optic neuritis, and neuropathy occurred after treatment with anti-TNF alpha therapy in collagen disease, and TNF antagonizing therapy showed worsening in a clinical trial with MS

  • Believing on the similarities of normal joints in humans and monkeys, we have employed a model of collagen-induced arthritis in Macaca fascicularis in an attempt to evaluate the histological alterations caused by such condition in the extracellular matrix of the articular cartilage

Read more

Summary

Introduction

Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations in a number of demyelinating disorders including multiple sclerosis (MS) and collagen diseases. Acute Serum Amyloid A (A-SAA) is an acute phase protein strongly expressed in rheumatoid arthritis (RA) synovial tissue (ST) critically involved in regulating cell migration and angiogenesis These processes are dependent on downstream interactions between extracellular matrix and cytoskeletal components. Conclusions: These results indicate that Egr-1 contributes to IL-1mediated down-regulation of PPARg expression in OA chondrocytes and suggest that this pathway could be a potential target for pharmacologic intervention in the treatment of OA and possibly other arthritic diseases. Immune cell-derived microparticles (MPs) are present at increased amounts in synovial fluid of rheumatoid arthritis (RA) patients [1] and can activate disease-relevant signalling pathways in RA synovial fibroblasts (SF) [2,3].

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call